David G. Nathan

Q: What Schools Are Affiliated With David G. Nathan

David G. Nathan is affiliated with the following schools: George Washington University, Albert Einstein College of Medicine, Massachusetts Institute of Technology, Massachusetts General Hospital, Duke University, Harvard University

David G. Nathan's AcademicInfluence.com Rankings

David G. Nathan

Medical

#103

World Rank

#168

Historical Rank

#53

USA Rank

Pediatrics

World Rank

Historical Rank

USA Rank

medical Degrees

Download Badge

Medical

David G. Nathan's Degrees

Doctorate Medicine Harvard University

Why Is David G. Nathan Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David Gordon Nathan is a pediatrician and hematologist. He is known for his authorship of Nathan and Oski's Hematology of Infancy and Childhood, a standard reference in pediatrics, currently in its seventh edition. Nathan remains an author on the current edition. Now retired, he was Robert A. Stranahan professor of pediatrics at Harvard Medical School and served as president of the Dana–Farber Cancer Institute. He was born in Boston.

(See a Problem?)

David G. Nathan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes Mellitus (1993) (19715)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (2002) (17532)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. (2005) (4036)
Follow-up report on the diagnosis of diabetes mellitus. (2003) (3690)
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes (2009) (2534)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) (2459)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. (2009) (2301)
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (2010) (2087)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2009) (1820)
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (2013) (1520)
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes (2007) (1502)
Translating the A1C Assay Into Estimated Average Glucose Values (2008) (1491)
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. (2000) (1434)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview (2013) (1325)
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants (2009) (1100)
Tests of glycemia in diabetes. (1995) (1089)
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy (2006) (997)
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. (2006) (958)
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. (2007) (891)
Quantitative nitroblue tetrazolium test in chronic granulomatous disease. (1968) (857)
Hematology of Infancy and Childhood (1974) (838)
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002) (835)
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. (2003) (832)
A prospective study of exercise and incidence of diabetes among US male physicians. (1992) (820)
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. (2006) (796)
Survival in Medically Treated Patients with Homozygous β-Thalassemia (1994) (781)
The clinical information value of the glycosylated hemoglobin assay. (1984) (769)
Impaired Fasting Glucose and Impaired Glucose Tolerance (2007) (769)
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002) (767)
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008) (744)
A clinical trial to maintain glycemic control in youth with type 2 diabetes. (2012) (729)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums (2018) (710)
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. (1999) (625)
Long-term complications of diabetes mellitus. (1993) (621)
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). (2009) (594)
Glucose levels and risk of dementia. (2013) (588)
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations (2016) (567)
The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. (2001) (558)
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. (2000) (554)
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. (1999) (552)
Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study (1997) (543)
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. (1976) (536)
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. (2002) (530)
Outpatient glycemic control with a bionic pancreas in type 1 diabetes. (2014) (524)
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. (2003) (500)
Insulin sensitivity during combined androgen blockade for prostate cancer. (2006) (489)
Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized? (2011) (482)
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. (1984) (475)
Relationship between glycated haemoglobin levels and mean glucose levels over time (2007) (463)
Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited (2008) (460)
Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse (1984) (456)
Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study (2015) (455)
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. (2005) (453)
Survival in medically treated patients with homozygous beta-thalassemia. (1994) (434)
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. (1979) (416)
A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes (2010) (406)
Leukocyte Oxidase: Defective Activity in Chronic Granulomatous Disease (1967) (402)
Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF (1986) (396)
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2008) (385)
Initial Management of Glycemia in Type 2 Diabetes Mellitus (2002) (373)
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. (2015) (362)
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations (2016) (361)
Effect of Aging on A1C Levels in Individuals Without Diabetes (2008) (360)
Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. (1985) (354)
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. (2001) (351)
Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. (2005) (348)
Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. (1988) (334)
Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement (2007) (334)
The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. (2003) (334)
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. (2008) (327)
Diabetes: Advances in Diagnosis and Treatment. (2015) (325)
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes (2009) (321)
The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention Program (2007) (314)
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? (2011) (312)
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. (2011) (311)
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. (2016) (308)
Decreased cognitive function in aging non-insulin-dependent diabetic patients. (1984) (305)
Implications of the United kingdom prospective diabetes study. (2003) (300)
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial (2003) (299)
The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it? (1997) (299)
Insulinotropic Action of Glucagonlike Peptide-I-(7–37) in Diabetic and Nondiabetic Subjects (1992) (295)
Association of HbA1c With Prevalent Cardiovascular Disease in the Original Cohort of the Framingham Heart Study (1992) (294)
Continuous subcutaenous administration of deferoxamine in patients with iron overload. (1977) (290)
Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. (2012) (290)
Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. (2006) (279)
Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. (2008) (271)
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. (2005) (271)
Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans (2010) (262)
Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. (1985) (261)
The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study (2006) (258)
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions (2013) (247)
A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. (2000) (245)
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. (1978) (244)
Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. (1999) (243)
Thalassemia: the consequences of unbalanced hemoglobin synthesis. (1966) (238)
Selection of patients for bone marrow transplantation in severe aplastic anemia. (1975) (236)
Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC (2014) (231)
A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. (2003) (231)
Finding new treatments for diabetes--how many, how fast... how good? (2007) (225)
Treatment of acute myelogenous leukemia in children and adults. (1980) (220)
Clinical Research: Perceptions, Reality, and Proposed Solutions (1998) (216)
Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. (2002) (214)
Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) (2013) (212)
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. (2014) (211)
A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. (2004) (210)
Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring Study (1998) (209)
Single-Void Urine Samples Can Be Used To Estimate Quantitative Microalbuminuria (1987) (206)
Pulmonary hypertension and nitric oxide depletion in sickle cell disease. (2010) (206)
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus (2002) (204)
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. (1983) (201)
Screening for Diabetic Retinopathy (1992) (199)
Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. (2006) (199)
Psychological and behavioral correlates of baseline BMI in the diabetes prevention program (DPP). (2002) (192)
Effect of Aging on A1C Levels in Persons without Diabetes: Evidence from the Framingham Offspring Study and NHANES 2001-2004 (2008) (191)
Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica. (2003) (184)
Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (2013) (182)
Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. (1978) (179)
Prevalence of Hyper- and Hypoglycemia Among Inpatients With Diabetes (2007) (179)
Advances in Diagnosis and Treatment (2016) (177)
Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study (2013) (176)
Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. (2004) (176)
Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas (2012) (174)
Globin chain synthesis in the alpha thalassemia syndromes. (1968) (171)
Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. (1969) (169)
Clinical inertia in the management of Type 2 diabetes metabolic risk factors (2004) (169)
Position Statement Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2011) (166)
Reassessment of the use of desferrioxamine B in iron overload. (1976) (166)
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. (1987) (166)
Impact of Intensive Lifestyle Intervention on Depression and Health-Related Quality of Life in Type 2 Diabetes: The Look AHEAD Trial (2014) (163)
Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. (1985) (159)
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. (2016) (157)
Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study (2011) (157)
Psychological predictors of physical activity in the diabetes prevention program. (2006) (157)
The prevention of type 2 diabetes (2008) (155)
Retinopathy in Older Type II Diabetics Association With Glucose Control (1986) (153)
The Genetic Landscape of Diamond-Blackfan Anemia (2018) (151)
The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance (1996) (150)
Diabetic Myocardial Infarction: Interaction of Diabetes With Other Preinfarction Risk Factors (1989) (149)
Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes (2014) (149)
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. (1983) (149)
Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes (2013) (148)
The Pathophysiology of Diabetic Complications: How Much Does the Glucose Hypothesis Explain? (1996) (146)
Plasma 25-Hydroxyvitamin D and Progression to Diabetes in Patients at Risk for Diabetes (2012) (145)
Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study. (2002) (144)
Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. (2009) (144)
The molecular basis of α-thalassemias: Frequent occurrence of dysfunctional α loci among non-Asians with Hb H disease (1979) (141)
Transfusion management of sickle cell disease. (1993) (141)
Tests of glycemia in diabetes mellitus. Their use in establishing a diagnosis and in treatment. (1989) (138)
Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. (1985) (134)
Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3. (1987) (134)
The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. (1997) (134)
Prenatal diagnosis of hemoglobinopathies. A review of 15 cases. (1976) (134)
Nathan and Oski's hematology of infancy and childhood (2013) (133)
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. (2007) (133)
Stages in the incorporation of fatty acids into red blood cells. (1968) (132)
Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. (1979) (131)
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. (1997) (131)
Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. (2008) (130)
Risk Factors for Cardiovascular Disease in Type 1 Diabetes (2016) (130)
Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes (2012) (130)
Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial (2017) (129)
Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. (1978) (128)
A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. (1992) (128)
A novel diagnostic screen for defects in the Fanconi anemia pathway. (2002) (125)
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. (1967) (125)
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. (1983) (125)
Rosiglitazone and cardiotoxicity--weighing the evidence. (2007) (124)
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study (2017) (124)
A Comparative Effectiveness Analysis of Three Continuous Glucose Monitors (2013) (120)
Type 2 Diabetes–Associated Missense Polymorphisms KCNJ11 E23K and ABCC8 A1369S Influence Progression to Diabetes and Response to Interventions in the Diabetes Prevention Program (2007) (120)
Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2011) (119)
Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. (1987) (118)
Nathan and Oski's hematology and oncology of infancy and childhood / (2015) (118)
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. (2002) (117)
Fetal erythropoiesis following bone marrow transplantation. (1976) (114)
Long-Term Complications in Youth-Onset Type 2 Diabetes. (2021) (114)
A Comparative Effectiveness Analysis of Three Continuous Glucose Monitors (2014) (113)
Pathophysiology and Clinical Manifestations of the β-Thalassemias. (2012) (113)
Congenital hemolytic anemia with high sodium, low potassium red cells. I. Studies of membrane permeability. (1968) (112)
Diamond-Blackfan anemia. Natural history and sequelae of treatment. (1996) (112)
ERYTHROPOIESIS IN ANEPHRIC MAN. (1964) (112)
Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial (2005) (112)
Demonstration of burst-promoting activity of recombinant human GM-CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin. (1985) (111)
Sickle cell disease and stroke. (2009) (111)
RNA and protein evidence for haplo‐insufficiency in Diamond–Blackfan anaemia patients with RPS19 mutations (2004) (110)
Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. (2002) (109)
Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. (1970) (107)
Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin. (1986) (107)
Measuring Psychological Insulin Resistance (2008) (106)
Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. (1970) (105)
Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants. (1971) (105)
HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study (2010) (105)
Pretreatment, Psychological, and Behavioral Predictors of Weight Outcomes Among Lifestyle Intervention Participants in the Diabetes Prevention Program (DPP) (2012) (104)
Careers in translational clinical research-historical perspectives, future challenges. (2002) (103)
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. (2014) (102)
Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes (1992) (102)
Cognitive and affective disorders in elderly diabetics. (1990) (102)
First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. (2003) (101)
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. (1989) (100)
Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know. (2010) (100)
Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure? (2006) (100)
How Doctors Choose Medications to Treat Type 2 Diabetes (2007) (99)
Novel Association of HK1 with Glycated Hemoglobin in a Non-Diabetic Population: A Genome-Wide Evaluation of 14,618 Participants in the Women's Genome Health Study (2008) (98)
Glycemic control in diabetes mellitus: have changes in therapy made a difference? (1996) (98)
Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial (2008) (98)
Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency. (1971) (96)
Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus. (2015) (95)
The clinical application of genetic testing in type 2 diabetes: a patient and physician survey (2009) (95)
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. (2013) (95)
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2007) (95)
Acute Hemodynamic Effects of Red Cell Volume Reduction in Polycythemia of Cyanotic Congenital Heart Disease (1970) (94)
Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes (2011) (93)
Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. (2002) (93)
The mortality of acquired aplastic anemia in children. (1972) (93)
Consensus statement on the worldwide standardisation of the HbA 1c measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation (2007) (92)
Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial. (2001) (92)
Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia. (1986) (92)
Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. (1972) (92)
New approaches to the transfusion management of thalassemia. (1980) (91)
Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells (1978) (91)
Academic freedom in clinical research. (2002) (89)
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. (2010) (89)
Musculoskeletal Complications in Type 1 Diabetes (2014) (89)
Congenital hemolytic anemia associated with dehydrated erythrocytes and increased potassium loss. (1974) (89)
Implications of the diabetes prevention program and Look AHEAD clinical trials for lifestyle interventions. (2008) (88)
Factors Associated With Diabetes Onset During Metformin Versus Placebo Therapy in the Diabetes Prevention Program (2007) (87)
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. (1996) (87)
Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. (1983) (87)
Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women. (1997) (86)
Memory self-assessment and performance in aged diabetics and non-diabetics. (1987) (86)
Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. (1971) (85)
Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. (1988) (84)
Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease. (2001) (84)
Myocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus (2011) (83)
Improved prognosis for patients with mediastinal lymphoblastic lymphoma. (1979) (83)
Does Glucose Variability Influence the Relationship Between Mean Plasma Glucose and HbA1c Levels in Type 1 and Type 2 Diabetic Patients? (2011) (83)
Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. (1988) (83)
Associations Between Features of Glucose Exposure and A1C (2010) (81)
Frequency of Evidence‐Based Screening for Retinopathy in Type 1 Diabetes (2017) (81)
Rapid Identification of Myocardial Infarction Risk Associated With Diabetes Medications Using Electronic Medical Records (2009) (81)
Detection of the sickle gene in the human fetus. Potential for intrauterine diagnosis of sickle-cell anemia. (1972) (80)
Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia. (2012) (80)
Non-insulin-dependent diabetes in older patients. Complications and risk factors. (1986) (80)
Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes. (2008) (79)
Energy metabolism in human erythrocytes. I. Effects of sodium fluoride. (1971) (79)
Congenital hemolytic anemia with high-sodium, low-potassium red cells. Studies of three generations of a family with a new variant. (1969) (79)
Clinical research and the NIH--a report card. (2003) (79)
HbA1c as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial (2014) (77)
Intensive diabetes therapy and ocular surgery in type 1 diabetes. (2015) (77)
Positive and negative elements regulate human interleukin 3 expression. (1990) (76)
Extreme Hemolysis and Red-Cell Distortion in Erythrocyte Pyruvate Kinase Deficiency (1964) (76)
Age and diabetes related changes in verbal fluency. (1987) (76)
Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring (2016) (76)
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. (2004) (75)
Postprandial blood glucose. American Diabetes Association. (2001) (75)
Influence of hemoglobin precipitation on erythrocyte metabolism in alpha and beta thalassemia. (1969) (75)
One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus. (1999) (75)
Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals (2014) (74)
Metabolomic profiling in the prediction of gestational diabetes mellitus (2015) (74)
Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge. (2012) (73)
The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. (1994) (72)
The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women (2001) (71)
The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial (2007) (71)
Labile glycosylated hemoglobin contributes to hemoglobin A1 as measured by liquid chromatography or electrophoresis. (1981) (70)
THE TURNOVER OF HEMOGLOBINS A, F, AND A(2) IN THE PERIPHERAL BLOOD OF THREE PATIENTS WITH THALASSEMIA. (1963) (70)
Clinical research: perceptions, reality, and proposed solutions. National Institutes of Health Director's Panel on Clinical Research. (1998) (70)
Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients with Type 2 Diabetes and A 1 C < 7 % (2007) (70)
Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. (1993) (69)
The passage of ammonia across the blood-brain-barrier and its relation to blood pH. (1958) (69)
A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). (2004) (67)
Combinations of recombinant colony-stimulating factors are required for optimal hematopoietic differentiation in serum-deprived culture. (1989) (67)
A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. (1990) (67)
Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. (1996) (66)
Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. (1974) (66)
Isolation of a human stromal cell strain secreting hemopoietic growth factors (1986) (65)
Differential binding of erythroid and myeloid progenitors to fibroblasts and fibronectin. (1987) (64)
Thiazolidinediones for initial treatment of type 2 diabetes? (2006) (64)
Beta-thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the beta-globin gene. (1989) (64)
New approaches to the transfusion management of thalassemia (1980) (63)
Thalassemia: an overview of 50 years of clinical research. (2010) (63)
Gamma-beta thalassemia: a cause of hemolytic disease of the newborn. (1972) (62)
Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study. (1982) (62)
Effect of aspirin on determinations of glycosylated hemoglobin. (1983) (62)
Value of Risk Stratification to Increase the Predictive Validity of HbA1c in Screening for Undiagnosed Diabetes in the US Population (2008) (62)
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008) (61)
Diamond Blackfan anemia treatment: past, present, and future. (2011) (60)
Differential binding of erythroid and myeloid progenitors to fibroblasts and fibronectin (1987) (59)
Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus (2001) (59)
Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing. (1992) (59)
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes (2007) (59)
The acute and transient nature of idiopathic immune hemolytic anemia in childhood. (1976) (58)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2009) (57)
Antenatal diagnosis of thalassaemia major. (1978) (57)
The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study (2017) (57)
Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. (1994) (56)
High fetal hemoglobin production in sickle cell anemia in the eastern province of Saudi Arabia is genetically determined (1986) (56)
Self-Reported Autoimmune Disease by Sex in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study (2014) (56)
Life-span and organ sequestration of the red cells in pyruvate kinase deficiency. (1968) (55)
Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. (1990) (55)
Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation. (1984) (55)
Associations of Adiponectin , Resistin , and Tumor Necrosis Factor-with Insulin Resistance (2008) (54)
Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment (2017) (54)
Determinants of retinopathy progression in type 1 diabetes mellitus. (1999) (54)
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications (2016) (54)
Targeting iNKT cells for the treatment of sickle cell disease. (2011) (54)
Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation (1980) (53)
Beta thalassemia and translation of globin messenger RNA. (1971) (53)
Standards of Care for Diabetes (1994) (53)
The role of red cell energy metabolism in the generation of irreversibly sickled cells in vitro. (1973) (52)
Inferences and Implications: Do results from the Diabetes Control and Complications Trial apply in NIDDM? (1995) (51)
Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study (2010) (51)
The National Institutes of Health and clinical research: a progress report (2000) (51)
Allogeneic bone marrow transplantation for chronic granulomatous disease. (1982) (50)
Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. (1978) (50)
Blood volume changes in cyanotic congenital heart disease. (1971) (50)
Regulation of Hematopoiesis (1990) (49)
Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study. (1998) (49)
Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study (2017) (49)
Acute methemoglobinemia and hemolytic anemia with phenazopyridine: possible relation to acute renal failure. (1977) (48)
The treatment of Cooley's anemia. (1990) (48)
Hemoglobin Syracuse (alpha2beta2-143(H21)His leads to Pro), a new high-affinity variant detected by special electrophoretic methods. Observations on the auto-oxidation of normal and variant hemoglobins. (1975) (48)
Hereditary xerocytosis revisited (2014) (47)
Androgens and erythropoiesis. 3. Further evaluation of testosterone treatment of myelofibrosis. (1966) (47)
Relation of Beta to Gamma Synthesis During the First Trimester: An Approach to Prenatal Diagnosis of Thalassemia (1974) (47)
Studies of the production and life span of erythrocytes in myeloid metaplasia. (1959) (47)
The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial (2017) (46)
Regulation of hemoglobin synthesis. Preferential inhibition of and globin synthesis. (1972) (46)
Hereditary hemolytic anemia associated with abnormal membrane lipids: mechanism of accumulation of phosphatidyl choline. (1971) (46)
Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia. (1994) (46)
A functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domain. (1991) (46)
Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells. (1978) (46)
Changes in fatty acid metabolism after erythrocyte peroxidation: stimulation of a membrane repair process. (1972) (45)
Retinal haemodynamics in individuals with well-controlled type 1 diabetes (2007) (44)
Depression and Diabetic Neuropathy: A Complex Relationship (1988) (44)
High fetal hemoglobin production in sickle cell anemia in the eastern province of Saudi Arabia is genetically determined. (1986) (44)
Role of Diabetologist in Evaluating Diabetic Retinopathy (1991) (43)
Programming pre-exercise snacks to prevent post-exercise hypoglycemia in intensively treated insulin-dependent diabetics. (1985) (43)
An Unusual Form of Chronic Neutropenia in a Father and Daughter with Hypogammaglobulinaemia (1977) (43)
Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes. (2011) (43)
Determining stability of stored samples retrospectively: the validation of glycated albumin. (2011) (43)
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment (1985) (42)
IRON DEFICIENCY ANEMIA ASSOCIATED WITH AN ERROR OF IRON METABOLISM IN TWO SIBLINGS. (1964) (42)
Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study (2011) (42)
Energy metabolism in human erythrocytes. II. Effects of glucose depletion. (1972) (42)
EXTREME HEMOLYSIS AND RED-CELL DISTORTION IN ERYTHROCYTE PYRUVATE KINASE DEFICIENCY. II. MEASUREMENTS OF ERYTHROCYTE GLUCOSE CONSUMPTION, POTASSIUM FLUX AND ADENOSINE TRIPHOSPHATE STABILITY. (1965) (42)
Incorporation of phosphatide precursors from serum into erythrocytes. (1970) (42)
The counting of barium carbonate in a liquid scintillation spectrometer. (1958) (41)
Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening. (2008) (41)
Reversing the hemoglobin switch. (2010) (41)
The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited. (2018) (41)
The red cell peroxide hemolysis test in the differential diagnosis of obstructive jaundice in the newborn period. (1971) (40)
Does diabetes prevention translate into reduced long-term vascular complications of diabetes? (2019) (40)
Rapid method for eliminating labile glycosylated hemoglobin from the assay for hemoglobin A1. (1982) (40)
ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial (2011) (39)
The Erythrocythaemic Effects of Androgen (1968) (39)
Energy Reserve and Cation Composition of Irreversibly Sickled Cell in Vivo (1978) (39)
Changes in Body Composition over Eight Years in a Randomized Trial of a Lifestyle Intervention: The Look AHEAD Study (2014) (38)
Equal synthesis of - and -globin chains in erythroid precursors in heterozygous -thalassemia. (1972) (38)
Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate. (1992) (38)
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. (1985) (38)
Efficacy Determinants of Subcutaneous Microdose Glucagon during Closed-Loop Control (2010) (38)
Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. (2000) (38)
Heterogeneity of DNA deletion in gamma delta beta-thalassemia. (1981) (37)
In utero diagnosis of: hemoglobinopathies. Hemoglobin synthesis in fetal red cells. (1974) (37)
A Rapid Chemical Means for Removing Labile Glycohemoglobin (1981) (37)
The childhood leukemias. (1981) (37)
Navigating the choices for diabetes prevention. (2010) (37)
C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. (2008) (36)
Influence of hydroxyurea on fetal hemoglobin production in vitro. (1987) (36)
Intracellular univalent cations and the regulation of the BALB/c-3T3 cell cycle (1981) (36)
Congenital bone marrow failure syndromes. (2000) (36)
Gaps in the glycation gap hypothesis. (2011) (36)
The several Cs of translational clinical research. (2005) (36)
T‐cell acute lymphoblastic leukaemia with late developing Philadelphia chromosome (1984) (35)
Effects of urea and cyanate on sickling in vitro. (1972) (35)
Normal and variant isoenzymes of human blood cell hexokinase and the isoenzyme patterns in hemolytic anemia. (1970) (35)
Screening for diabetes mellitus. (1988) (35)
Concentration of fetal red blood cells from a mixture of maternal and fetal blood by anti-i serum--an aid to prenatal diagnosis of hemoglobinopathies. (1974) (34)
Stromal cell-associated erythropoiesis. (1986) (34)
Long-term effect of diabetes and its treatment on cognitive function (2007) (34)
Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties. (1985) (34)
Long-Term Therapy of IDDM With an Implantable Insulin Pump (1997) (33)
Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNAs are produced by a small fraction of blood mononuclear cells. (1989) (33)
Prenatal diagnosis of hemoglobinopathies. (1979) (33)
An orally active iron chelator. (1995) (33)
Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program (2012) (33)
CELL‐CELL INTERACTIONS IN THE REGULATION OF ERYTHROPOIESIS (1983) (32)
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. (2017) (32)
Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia. (1985) (32)
Expression and function of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit. (1994) (32)
A low-affinity human granulocyte-macrophage colony-stimulating factor/murine erythropoietin hybrid receptor functions in murine cell lines. (1993) (31)
Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial (2020) (31)
Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study (2018) (31)
Medical nutrition therapy for hypercholesterolemia positively affects patient satisfaction and quality of life outcomes (2002) (31)
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. (2010) (31)
Metabolic response to three years of continuous, basal rate intravenous insulin infusion in type II diabetic patients. (1985) (31)
New developments in iron chelators (2005) (31)
Exercise-induced hemolysis in xerocytosis. Erythrocyte dehydration and shear sensitivity. (1981) (31)
Educational-debt relief for clinical investigators--a vote of confidence. (2002) (31)
THALASSEMIA TRAIT. GENETIC COMBINATIONS OF INCREASED FETAL AND A2 HEMOGLOBINS. (1964) (31)
Opportunities for medical research in the 21st century. (2001) (31)
Use of homologous platelet survival in differential diagnoses of chronic thrombocytopenia in childhood. (1977) (30)
Synthesis of hemoglobin F in adult simian erythroid progenitor-derived colonies. (1982) (30)
Enhanced expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor subunits in murine hematopoietic cells stimulated with hematopoietic growth factors. (1992) (30)
Hereditary hemolytic anemia associated with abnormal membrane lipid. II. Ion permeability and transport abnormalities. (1973) (29)
Response of three classes of human erythroid progenitors to the absence of erythropoietin in vitro as a measure of progenitor maturity. (1981) (29)
The reaction of cyanate with the alpha and beta subunits in hemoglobin. Effects of oxygenation, phosphates, and carbon dioxide. (1973) (29)
Diets for Insulin Pump and Multiple Daily Injection Therapy (1983) (29)
Bedside capillary glucose measurement by staff nurses in a general hospital. (1986) (28)
Sodium and potassium concentration and transmembrane fluxes in leukocytes. (1974) (28)
Exome sequencing identifies GATA 1 mutations resulting in Diamond-Blackfan anemia (2012) (28)
NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease (2017) (28)
U-500 insulin in the treatment of antibody-mediated insulin resistance. (1981) (28)
The role of adenosine signaling in sickle cell therapeutics. (2014) (28)
ERYTHROCYTE PRODUCTION AND METABOLISM IN ANEPHRIC AND UREMIC MEN * (1968) (28)
NF-κB Is Activated in CD4+ iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A2A Receptors (2013) (28)
Editorial: NBT reduction by human phagocytes. (1974) (28)
Rubbish in the red cell. (1969) (27)
The effect of desferrithiocin, an oral iron chelator, on T-cell function. (1990) (27)
Effects of large doses of androgen on rodent erythropoiesis and body composition. (1965) (27)
Effect of Glycemic Treatment and Microvascular Complications on Menopause in Women With Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort (2014) (27)
Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program (2017) (27)
Energy metabolism in human erythrocytes: the role of phosphoglycerate kinase in cation transport. (1975) (27)
THE METABOLISM OF THE INDIVIDUAL C14 LABELED HEMOGLOBINS IN PATIENTS WITH H-THALASSEMIA, WITH OBSERVATIONS ON RADIOCHROMATE BINDING TO THE HEMOGLOBINS DURING RED CELL SURVIVAL. (1965) (27)
The beneficence of neonatal hematopoiesis. (1989) (27)
A non‐human primate model for the study of oral iron chelators (1989) (27)
Indium Chloride Scintigraphy: An Index of Severity in Patients with Aplastic Anaemia (1976) (27)
Red cell aplasia in children. (1979) (26)
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study (2012) (26)
Erythrocyte ion transport defects and hemolytic anemia: "hydrocytosis" and "desiccytosis". (1970) (26)
Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes (2018) (26)
Ice cream in the diet of insulin-dependent diabetic patients. (1984) (26)
Tests of Glycemia in Diabetes (1995) (26)
Prevention of long-term complications of non-insulin-dependent diabetes mellitus. (1995) (26)
The molecular genetics of thalassemia. (1981) (26)
Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation. (1973) (26)
Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program (2014) (26)
Expression of the beta-thalassemia gene in the first trimester fetus. (1975) (26)
Amino acid oxidase of leukocytes in relation to H 2 O 2 -mediated bacterial killing. (1971) (26)
Two commercial methods evaluated for eliminating the labile fraction from the assay for glycated hemoglobin (glycohemoglobin). (1984) (25)
Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease. (2014) (25)
Treatment of iron overload in adults with continuous parenteral desferrioxamine. (1977) (25)
Advances in Sickle Cell Therapies in the Hydroxyurea Era (2014) (25)
Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia (1993) (25)
Bone marrow transplantation for an infant with neutrophil dysfunction. (1977) (24)
DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (24)
Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report. (1976) (24)
Cooperation between Core Binding Factor and Adjacent Promoter Elements Contributes to the Tissue-specific Expression of Interleukin-3* (1996) (24)
Thy‐1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors (1985) (24)
Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus. (2009) (24)
Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study (2022) (24)
Realising the long-term promise of insulin therapy: the DCCT/EDIC study (2021) (24)
Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. (2010) (24)
Efficacy of a short course (four doses) of methotrexate following bone marrow transplantation for prevention of graft-versus-host disease. (1985) (23)
successful Treatment of Extremely Brittle, Insulin-dependent Diabetes with a Novel Subcutaneous Insulin Pump Regimen (1982) (23)
Analysis of hemoglobin F production in Saudi Arabian families with sickle cell anemia. (1987) (23)
Modern management of insulin-dependent diabetes mellitus. (1988) (23)
Association of Concussion Symptoms With Testosterone Levels and Erectile Dysfunction in Former Professional US-Style Football Players (2019) (23)
The A1c-derived Average Glucose (ADAG) Study Group: Translating the A1C assay into estimated average glucose values (Diabetes Care (2008) 31(1473-1478)) (2009) (23)
The synthesis of heme and globin in the maturing human erythroid cell. (1961) (23)
Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major. Commentary (2008) (22)
NIH support for basic and clinical research: biomedical researcher angst in 2006. (2006) (22)
Beta Thalassemia Trait: Detection at Birth (1968) (22)
Diabetes in ageing: pathways for developing the evidence base for clinical guidance. (2020) (22)
Monocytes do not inhibit peripheral blood erythroid burst forming unit colony formation. (1980) (22)
The effect of amphotericin B on erythrocyte membrane cation permeability: its relation to in vivo erythrocyte survival. (1969) (21)
Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia. (1993) (21)
The role of red blood cell organic phosphates in adaptation to congenital heart disease. (1971) (21)
Clinical removal of iron. (1982) (21)
Combined kidney and pancreas transplantation in diabetics. (1988) (21)
Determination of the hemoglobin F program in human progenitor-derived erythroid cells. (1985) (21)
Point‐of‐Care Testing for Diabetes (2002) (21)
Erythroid cell maturation and hemoglobin synthesis in megaloblastic anemia. (1962) (21)
The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. (1996) (21)
Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. (1993) (20)
Nesidioblastosis Associated with Insulin-mediated Hypoglycemia in an Adult (1981) (20)
Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (Nature Genetics (2010) 42 (105-116)) (2010) (20)
EXTREME HEMOLYSIS AND RED-CELL DISTORTION IN ERYTHROCYTE PYRUVATE KINASE DEFICIENCY. I. MORPHOLOGY, ERYTHROKINETICS AND FAMILY ENZYME STUDIES. (1964) (20)
Fluorometric analysis of glycolytic intermediates and pyridine nucleotides in peripheral blood cells. (1971) (20)
Hematopoiesis in vitro coexists with natural killer lymphocytes. (1989) (19)
Convenient automated method for liquid-chromatographic measurement of glycated hemoglobin. (1984) (19)
Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes: response to McCarter et al. (2005) (19)
Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial (2015) (19)
Analysis of Hemoglobin F Production in Saudi Arabian Families With Sickle Cell Anemia (1987) (19)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study: 30th Anniversary Presentations (2013) (19)
Toxic effects of high-dose cyanate administration in rodents. (1974) (19)
The Importance of Intensive Supervision in Determining the Efficacy of Insulin Pump Therapy (1983) (19)
Detection of leukemia-related karyotypes in granulocyte/macrophage colonies from a patient with acute myelomonocytic leukemia. (1983) (18)
Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC) (2021) (18)
Longitudinal Changes in the Relationship Between Hemoglobin A1c and Glucose Tolerance Across Pregnancy and Postpartum. (2020) (18)
Health care resource utilization associated with a diabetes center and a general medicine clinic (2007) (18)
Aplastic and hypoplastic anemia. (1980) (18)
Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study (2010) (18)
A screening algorithm to identify clinically significant changes in neuropsychological functions in the Diabetes Control and Complications Trial. DCCT Research Group. (1994) (18)
Basal-Rate Intravenous Insulin Infusion Compared to Conventional Insulin Treatment in Patients With Type II Diabetes: A Prospective Crossover Trial (1989) (18)
Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group. (1997) (18)
Hemoglobin Alc--infatuation or the real thing? (1990) (18)
Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals. Diabetes Care 2014;37:1048–1051 (2014) (18)
The rationale for glucose control in diabetes mellitus. (1992) (18)
Trials That Matter: Rosiglitazone, Ramipril, and the Prevention of Type 2 Diabetes (2007) (18)
Effect of hospital admission on glycemic control 1 year after discharge. (2012) (17)
The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease. (1979) (17)
A colorimetric method for the measurement of the brain ammonia of the mouse; the effect of glutamine on the total measurable ammonia. (1959) (17)
Pathophysiology and Clinical Manifestations of the b -Thalassemias (2012) (17)
Targeting the Cell Death-Survival Equation (2007) (17)
Buffy-coat observations and red-cell antibodies in acquired hemolytic anemia. (1971) (17)
Reticulocyte survival in sickle cell anemia: effect of cyanate. (1972) (16)
Key Learning from the Dana-Farber Cancer Institute's 10-Year Patient Safety Journey (2006) (16)
Response to Rodríguez-Segade et al. and Leslie and Kilpatrick Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. (2009) (16)
Tests of glycemia in diabetes. (2004) (16)
LIQUID SCINTILLATION COUNTING OF C14-LABELED HEMOGLOBIN AND HEMIN BY A MODIFIED SCHOENIGER TECHNIQUE. (1963) (16)
Thalassemia: The Continued Challenge (2005) (16)
Hydroxyurea increases fetal hemoglobin production in sickle cell anemia. (1984) (16)
Bone marrow transplantation for thalassemia. (1987) (16)
COVID-19, nuclear war, and global warming: lessons for our vulnerable world (2020) (16)
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis (2007) (16)
Studies on the folic acid vitamins. VI. The effect of amethopterin on erythropoiesis in man (1960) (16)
Inhaled Insulin for Type 2 Diabetes: Solution or Distraction? (2001) (15)
Screening for Diabetes: Can We Afford Not To Screen? (2004) (15)
Prenatal diagnosis of sickle-cell anemia and alpha G Philadelphia. Study of a Fetus also at risk for H b S/beta+-thalassemia. (1976) (15)
Comparison of energy assessment methods in overweight individuals. (2014) (15)
The Genetic Landscape of Diamond-Blackfan Anemia. (2019) (14)
Evidence for a clonal model for hemoglobin switching. (1983) (14)
Congenital bone marrow failure syndromes (2000) (14)
of the National Heart , Lung , and Blood Institute – National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus (2005) (14)
The relationship of total red cell volume to total body water in octogenarian males. (1962) (14)
Concussion and Risk of Chronic Medical and Behavioral Health Comorbidities. (2021) (14)
The thalassemias. (1976) (14)
PRENATAL DIAGNOSIS OF HEMOGLOBINOPATHIES: THE NEW ENGLAND APPROACH * (1980) (14)
Hyperproinsulinemia in Type II Diabetes (1992) (13)
The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes (2021) (13)
Hematology of infancy and childhood: Third edition (1987) (13)
Studies of the rate of production and life span of erythrocytes in acute leukemia. (1959) (13)
Glycemic control after hospital discharge in insulin-treated type 2 diabetes: a randomized pilot study of daily remote glucose monitoring. (2015) (13)
Decreased hematopoietic accessory cell function following bone marrow transplantation. (1987) (13)
Isolated pancreas transplantation for type 1 diabetes: a doctor's dilemma. (2003) (13)
Erratum: Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group (Kidney International 43 (1993) 668-674) (1993) (13)
INTRAUTERINE DIAGNOSIS OF THALASSEMIA (1974) (13)
Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study. (2022) (13)
The Impact of Clinical Trials on the Treatment of Diabetes Mellitus (2002) (13)
THE EFFECT OF ANDROGENS ON SOME ASPECTS OF BODY COMPOSITION AND ERYTHROPOISIS IN OCTOGENARIAN MALES * (1963) (13)
Time for Clinically Relevant Comparative Effectiveness Studies in Type 2 Diabetes (2011) (13)
Point-of-care testing for diabetes. (2004) (12)
Editorial retrospective. Erythropoietin and the regulation of erythropoiesis. (1983) (12)
Treating Type 2 Diabetes with Respect (1999) (12)
Antenatal diagnosis of haematological disorders--'1978'. (1978) (12)
Deferiprone and hepatic fibrosis. (2003) (12)
Regulation of erythropoiesis. (1977) (12)
Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering. (2014) (12)
Inhibition of hemoglobin synthesis by cyanate in vitro. (1974) (12)
Comprehensive Cancer Centres and the war on cancer (2001) (12)
Acute hemodynamic effects of red cell phoresis in secondary polycythemia with cyanotic congenital heart disease (1969) (11)
HYPOCHROMIC ANEMIA AND HEMOCHROMATOSIS. RESPONSE TO COMBINED TESTOSTERONE, PYRIDOXINE, AND LIVER EXTRACT THERAPY (1962) (11)
Eulogy for the clinical research center. (2016) (11)
Labile GlycosylatedHemoglobinContributesto HemoglobinA., as Measured by Liquid Chromatographyor Electrophoresis (1981) (11)
Control of the simian fetal hemoglobin switch at the progenitor cell level. (1981) (11)
Molecular pathology of the thalassemias. (1976) (11)
Screening for sickle-cell trait and G-6-PD deficiency. (1970) (11)
Islet autoantibody positivity in overweight and obese adults with type 2 diabetes (2018) (11)
Splenectomy in the Wiskott-Aldrich syndrome. (1980) (11)
Congenital methemoglobinemia: the result of age-dependent decay of methemoglobin reductase. (1972) (11)
Association of Traumatic Brain Injury With the Risk of Developing Chronic Cardiovascular, Endocrine, Neurological, and Psychiatric Disorders (2022) (11)
Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study (2018) (11)
Tests of Glycemia in Diabetes (1997) (10)
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes. (2022) (10)
Oral iron chelators. (1990) (10)
Confounding in ex vivo models of Diamond-Blackfan anemia. (2017) (10)
Simultaneous nosocomial outbreaks caused by multiply resistant Klebsiella pneumoniae types 2 and 30 (1978) (10)
Disorders of phagocytic cell function. (1971) (10)
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes. (2019) (10)
The cancer treatment revolution. (2007) (10)
A Phase I Single Ascending Dose Study Of NKTT120 In Stable Adult Sickle Cell Patients (2013) (10)
The Effect of Excess Weight Gain with Intensive Diabetes Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Study (2012) (10)
F‐CELL REGULATION (1980) (10)
Adjunctive Treatments for Type 1 Diabetes. (2017) (9)
Careers chosen by graduates of a major pediatrics residency program, 1974‐1986 (1992) (9)
Cytogenetic evidence for involvement of erythroid progenitors in a child with therapy linked myelodysplasia (1986) (9)
Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study. (2001) (9)
Sickle cell disease (SCD), iNKT cells, and regadenoson infusion. (2012) (9)
Progress in diabetes research--what's next. (2009) (9)
A colorimetric procedure for the determination of blood ammonia. (1957) (9)
New methods of counting of C-14-labeled hemoglobin and hemin. (1967) (9)
Antithoracic duct lymphocyte globulin. (1983) (9)
Genes, Blood, and Courage: A Boy Called Immortal Sword (1998) (9)
Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes. (2022) (9)
The Glycemic Index: Meat and Potatoes or Just Gravy? (1987) (9)
Antithoracic duct lymphocyte globulin [letter] (1983) (9)
Saudi Arabian Sickle Cell Anemia a (1989) (8)
Hope for hematopoietic hormones. (1987) (8)
Using a multi-level B-spline model to analyze and compare patient glucose profiles based on continuous monitoring data. (2011) (8)
Pharmacologic Manipulation of Fetal Hemoglobin in the Hemoglobinopathies a (1990) (8)
Oxygen affinity independent action of cyanate and 2,3 DPG on sickling. (1972) (8)
An algorithm for the care of type 2 diabetes. (2009) (8)
Accuracy of a Point-of-Care Hemoglobin A1c Assay (2019) (8)
The future of care for type 1 diabetes (2013) (8)
Empirically Establishing Blood Glucose Targets to Achieve (2014) (8)
Glycemic management of type 2 diabetes: how tight is right and how to get there. (2008) (8)
Research navigating the course of clinical practice in diabetes. (2004) (8)
Counterpoint: No Time to Inhale: Arguments Against Inhaled Insulin in 2007 (2007) (7)
Understanding the long-term benefits and dangers of intensive therapy of diabetes. (2012) (7)
Manipulation of HbF production with hematopoietic growth factors. (1989) (7)
ADHESIVE CAPSULITIS OF THE SHOULDER : A COMPREHENSIVE STUDY (2001) (7)
Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differences (1985) (7)
Musings on genome medicine: genome wide association studies (2009) (7)
Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy (2018) (7)
Search for improved therapy of sickle cell anemia. (2002) (7)
The Role of Glycemia Management in the Prevention of Cardiovascular DiseaseStarting Over? (2009) (7)
Antenatal diagnosis of hemoglobinopathies: social and technical considerations. (1975) (7)
The merger of two pediatric residency programs: lessons learned. (2008) (7)
Influence of erythrocyte membrane adenosine triphosphatase on the metabolism of hemolysates. (1970) (7)
Severe hypoglycaemia in Diabetes Control and Complications Trial (1994) (7)
P Lack of Association Between the Trp 719 Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies (2010) (7)
Estimating HbA1c from timed Self-Monitored Blood Glucose values. (2018) (7)
Cognitive Function in Non-Insulin-Dependent Diabetes (1990) (7)
Association Between Change in Accelerometer-Measured and Self-Reported Physical Activity and Cardiovascular Disease in the Look AHEAD Trial. (2022) (7)
Identification of three accessory cell populations in human bone marrow with erythroid burst promoting properties. (1985) (7)
Small steps, large problems: advances in the management of diabetes mellitus. (2002) (6)
Therapy-linked leukemia. (1971) (6)
Fetal research: an investigator's view. (1977) (6)
In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia. (1983) (6)
Case 14-1968: Thalassemia in a Forty-Eight-Year-Old Man (1968) (6)
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases (2009) (6)
Iron Deficiency Anemia Associated with an Error of Iron Metabolism in Two Siblings: A Thirty Year Follow Up. (1996) (6)
Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783 (2017) (6)
Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study. (2020) (6)
The role of T lymphocytes in human erythropoiesis. (1981) (6)
Management of Insulin-Dependent Diabetes Mellitus (2012) (6)
Guidelines Versus Guidelines: What's Best for the Patient? (2018) (6)
Recapitulation of the immune response and haematopoietic system in bone marrow transplantation. (1983) (6)
Treating type 2 diabetes with respect. (1999) (6)
Current Therapy and New Approaches to the Treatment of Thalassemia Major (1985) (6)
Academic careers: choice and activity of graduates of a pediatric residency program 1974-1986. (1993) (6)
LOCI OF HUMAN HÆMOGLOBIN GENES (1967) (5)
Analysis of high fetal hemoglobin production in sickle cell anemia patients from the Eastern Province of Saudi Arabia. (1987) (5)
Cell-cell interactions in in vitro erythropoiesis. (1980) (5)
Moderation of the Effect of Glycemia on the Risk of Cardiovascular Disease in Type 1 Diabetes: the DCCT/EDIC Study. (2020) (5)
History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial (2020) (5)
Purification of rat hepatic glucokinase. (1986) (5)
Acute angle closure glaucoma following rapid correction of hyperglycemia. (2003) (5)
Antenatal Diagnosis of the Haemoglobinopathies (1975) (5)
Relative efficacy of subcutaneous infusions and bolus injections of deferoxamine in the removal of non-transferrin-bound iron (NTBI). (1998) (5)
The biological activities and uses of recombinant granulocyte-macrophage and multi-colony stimulating factors. (1987) (5)
Amino acid uptake in erythropoiesis (2015) (5)
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience (2022) (5)
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience (2022) (5)
Funding subspecialty training for clinical investigators. (1987) (5)
Iron chelation with oral deferiprone in patients with thalassemia. (1998) (5)
Thalassemia: the continued challenge. (2009) (5)
Frequency of Evidence-Based Screening for Diabetic Retinopathy. (2017) (5)
CHAPTER 1 CLASSIFICATION AND DIAGNOSIS OF DIABETES (2016) (5)
Comparative Metabolism of Hæmoglobins A and F in Thalassæmia (1962) (4)
Comment on Miller and Orchard: Understanding Metabolic Memory: A Tale of Two Studies. Diabetes 2020;69:291–299 (2020) (4)
Pioneers and modern ideas. Prospective on thalassemia. (1998) (4)
Comparative metabolism of haemoglobins A and F in thalassaemia. (1962) (4)
Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study (2018) (4)
Regulation of erythropoiesis and hemoglobin F production. (1983) (4)
Prenatal diagnosis of hemoglobinopathies: detection of alpha-thalassemia trait and of sickle cell disease in utero. (1977) (4)
Implantable insulin infusion devices. (1982) (4)
Heterogeneity of DNA Deletion in y8,6-Thalassemia (2003) (4)
Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study (2021) (4)
Regulation of Fetal Hemoglobin Synthesis in the Hemoglobinopathies (1985) (4)
Thalassemia: a look to the future (2016) (4)
Clinical review 146: The impact of clinical trials on the treatment of diabetes mellitus. (2002) (4)
The Levels of Oxidized LDL and AGE-LDL in Circulating Immune Complexes are strongly associated with increased levels of Carotid Intima-Media Thickness and its progression in Type 1 Diabetes Short title : Modified LDL in LDL-IC predict increased carotid IMT (2010) (4)
Medical management of hyperglycaemia in type 2 diabetes mellitus. Reply to Woo V [letter] and Eizirik DL [letter] (2009) (4)
Prospective on Thalassemia (1998) (4)
Blood Relations: Transfusion and the Making of Human Genetics Jenny Bangham Chicago, IL: University of Chicago Press, 2020 (2021) (4)
Evaluation of Iron Levels to Avoid the Clinical Sequelae of Iron Overload (2007) (4)
Lethal graft-versus-host disease: modification with allogeneic cultured donor cells. (1984) (4)
Erythrokinetic studies in primary hypersplenism with pancytopenia. (1962) (4)
Regulation of fetal hemoglobin synthesis by cell cycle specific drugs. (1985) (4)
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy (2006) (4)
The Preparation of an Acceptable Placebo for NPH Insulin (1985) (3)
Screening for Diabetes (1990) (3)
Hemoglobin F and beta thalassemia. (1967) (3)
NITROBLUE-TETRAZOLIUM TESTS (1975) (3)
505 SEPARATION OF FETAL AND ADULT ERYTHROCYTES BY SELECTIVE HEMOLYSIS: AN AID TO PERNTAL DIAGNOSIS OF HEMOGLOBINOPATHIES (1978) (3)
Musings on genome medicine: gene therapy (2009) (3)
Anemia in adolescence. 1. Disturbances of iron balance. (1975) (3)
Globin Chain Synthesis in the (1968) (3)
Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. (2022) (3)
The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS) (2022) (3)
VAPA10: a treatment program for acute myelocytic leukemia. (1981) (3)
Diabetes: Long-acting insulin analogues—are benefits worth the cost? (2012) (3)
The limited clinical value of home urine testing by diabetic patients (1986) (3)
The metabolic and bactericidal defect in chronic granulomatous disease. (1969) (3)
The Need for Accuracy in Hemoglobin A1c Proficiency Testing: Why the Proposed CLIA Rule of 2019 Is a Step Backward (2019) (3)
NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial (2014) (3)
The Trial to Assess Chelation Therapy 2 (TACT2): Rationale and Design. (2022) (3)
THALASSEMIA AS A PROLIFERATIVE DISORDER (1964) (3)
Hemoglobin disorders: a look to the future. (2013) (2)
The treatment of acute myelogenous leukemia in children and adults: VAPA update. (1983) (2)
Successful bone marrow transplantation in sensitized recipients. (1979) (2)
Pathophysiology of common hemolytic syndromes. (1971) (2)
Applying molecular genetics to a human disease (1975) (2)
Effects of erythroid hyperplasia on patterns of glycine-2-C-14 uptake in heme and globin of human peripheral blood in vivo. (1966) (2)
Secondary gout. (1961) (2)
ISOLATED THROMBOCYTOPENIA FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION (1984) (2)
Response to Comment on: Lachin et al. (2007) The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial: Diabetes 56:1913–1921, 2007 (2008) (2)
Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies (2021) (2)
Antibody-induced red cell aplasia. (1981) (2)
Progress in the methodology for antenatal diagnosis of the beta chain hemoglobinopathies. (1975) (2)
ANTENATAL DIAGNOSIS OF THE β-THALASSEMIA GENE (β-thal) (1974) (2)
Effect of a Long-Term Behavioral Weight Loss Intervention on Nephropathy in Overweight or Obese Adults with Type 2 Diabetes: the Look AHEAD Randomized Clinical Trial (2015) (2)
Saul Genuth, MD: Clinical Researcher and Leader in Developing Modern Diabetes Treatment (2015) (2)
A computational model of 1,5‐AG dynamics during pregnancy (2017) (2)
Smoking and cardiovascular risk in diabetes mellitus (2010) (2)
A cellular model for hemoglobin switching. (1982) (2)
Response to Cundy (2001) (2)
Partial deletion of ,3-globin gene DNA in certain patients with f#-thalassemia (2)
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience. (2022) (2)
Management of diabetes mellitus after the DCCT--what's next? (1995) (2)
PEDIATRIC BONE MARROW TRANSPLANTATION-A BIO-ETHICAL MODEL (1974) (2)
addition of erythropoietin on circulating erythroid progenitors using an assay involving the delayed Demonstration of burst-promoting activity of recombinant human GM-CSF (2011) (2)
Preventing type 2 diabetes: what have we learned? (2003) (2)
Insulin treatment in the elderly diabetic patient. (1990) (2)
Changes in mood and health‐related quality of life in Look AHEAD 6 years after termination of the lifestyle intervention (2021) (2)
Anemia in adolescence. 2. Hemoglobinopathies and other causes. (1975) (2)
DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (2)
Significance of split products of fibrin in serum of the newborn. (1969) (2)
Primary medical care and medical research training. (1973) (2)
A service chief model for general pediatric inpatient care and residency training. (1992) (2)
Clinical research: a tale of two studies. (2003) (2)
7 – Effect of Non-Insulin-Dependent Diabetes Mellitus on Gustation and Olfaction (1986) (2)
Guilt by association. (2011) (2)
To What Target Hemoglobin A1c Level Would You Treat This Patient With Type 2 Diabetes? (2019) (1)
Book Review Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management Edited by Martin H. Steinberg, Bernard G. Forget, Douglas R. Higgs, and Ronald L. Nagel. 1266 pp., illustrated. New York, Cambridge University Press, 2001. $275. 0-521-63266-8 (2001) (1)
Acceptance of the 2006 Kober medal. (2007) (1)
Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes (2022) (1)
Thalassemia: a progress report in applied molecular biology. (1973) (1)
Introduction to the regulation of hematopoiesis. (1988) (1)
[Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication]. (2009) (1)
Translation: Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. (2011) (1)
Happy Accidents: Serendipity in Modern Medical Breakthroughs-When Scientists Find What They Are NOT Looking For by Morton Meyers (2007) Arcade Publishing, New York. (2009) (1)
Musings on genome medicine: Hepatitis C (2010) (1)
The Jeremiah Metzger lecture. Regulation of hematopoiesis. (1990) (1)
Determination can win the battle (2004) (1)
Loci of human hemoglobin genes. (1967) (1)
Oral iron chelation: new drug, old rules (2008) (1)
Combinations of purified recombinant colony-stimulating factors are required for optimal hematopoietic differentiation. (1988) (1)
Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes. (2022) (1)
Leukemia and the regulation of hematopoiesis. (1987) (1)
Introduction: the molecular biology of hematopoiesis. (1991) (1)
Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis. (1977) (1)
Antenatal diagnosis of hemoglobinopathies: an exquisite molecular brew. (1976) (1)
Hydrogen Peroxide Hemolysis: A Test for Biliary Obstruction (1970) (1)
THE EFFECT OF LARGE DOSES OF TESTOSTERONE ON THE BODY FAT OF ELDERLY MEN. (1963) (1)
Serum urate and cardiovascular events in the DCCT/EDIC study (2021) (1)
Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring. (2019) (1)
NIH Support for Basic and Clinical Research (2017) (1)
Mild thalassemia--a guide to therapy. (1969) (1)
Gallium-67 scintigraphy in children with chronic granulomatous disease (2005) (1)
DISCUSSION PAPER: TRANSLATIONAL CONTROL OF HEMOGLOBIN SYNTHESIS IN THALASSEMIC BONE MARROW * (1974) (1)
The common metabolic pathway tored cell death in hemolytic anemias (1964) (1)
Book Review Hematopoietic Growth Factors in Clinical Applications Edited by Roland Mertelsmann and Friedhelm Herrmann. 496 pp., illustrated. New York, Marcel Dekker, 1990. $99.75. (1991) (1)
1,5 AnhydroGlucitol Concentrations and Measures of Glucose Control and Glucose Variability in T1DM and T2DM Patients (2009) (1)
Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448. (2022) (1)
MOLECULAR GENETICS OP THE β-THALASSEMIA (β-THAL) SYNDROMES (1974) (1)
Evidence for a second diamond-blackfan anemia gene on human chromosome 8p23-22, and for at least one other dba gene (2000) (1)
Acceptance of the 2003 John Howland Award: A Journey in Clinical Research (2004) (1)
Regulation of fetal hemoglobin synthesis in sickle cell anemia. (1987) (1)
Hemoglobin F and Beta Thalassemia (1967) (1)
Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson (2014) (1)
A revived opportunity for fetal research (1993) (1)
Progenitor Cells. (Book Reviews: Megakaryocyte Development and Function) (1987) (1)
Investigations of the simian ontogenic switch from fetal to adult hemoglobin at the progenitor cell level. (1986) (1)
Molecular Medicine Society (1995) (1)
Diabetes : the most comprehensive, up-to-date information available to help you understand your condition, make the right treatment choices, and cope effectively (1997) (1)
Monosomy 7 and the myeloid malignancies (2003) (1)
Ethical problems in fetal research. (1975) (1)
Perceptions, Reality, and Proposed Solutions (2016) (1)
A Life-Long Quest to Understand and Treat Genetic Blood Disorders (2010) (1)
Haemolysis due to pyruvate kinase deficiency and other glycolytic enzymopathies. (1975) (1)
A memory of Frank A. Oski (1997) (1)
Charles A. Janeway: Pediatrician to the World’s Children (2007) (1)
Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differences. (1985) (1)
Stanley J. Korsmeyer. (2007) (1)
Nathan's Response to Dumas (1994) (1)
Lipid and inflammatory risk worsens over 3 years in youth with type 2 diabetes: The TODAY clinical trial (2013) (1)
on clinical research & the future of medicine (2002) (1)
GLOBIN TRANSLATION IN THALASSEMIC BONE MARROW * (1974) (1)
Insulins for insulin resistance. (1981) (1)
The limited clinical value of home urine testing by diabetic patients (2007) (1)
Does the relationship between hemoglobin A1c and mean glucose levels differ by race? (2010) (1)
Data sharing is desirable, but benefits should not be exaggerated (2015) (1)
The βc Component of the Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)/Interleukin 3 (IL-3)/IL-5 Receptor Interacts with a Hybrid GM-CSF/Erythropoietin Receptor to Influence Proliferation and β-Globin mRNA Expression (1996) (1)
Journal of the American Medical Associa tion, June 1, 1984, p 2825 Ice cream in the diet of insulin- dependent diabetic patients (1984) (0)
Reply to M. F. Greaves "Speculations on the cause of childhood acute lymphoblastic leukemia". (1988) (0)
Diabetes Care Barriers, Use, and Health Outcomes in Younger Adults With Type 1 and Type 2 Diabetes. (2023) (0)
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes (2007) (0)
HbA1c and Mean Blood-Glucose Show Stronger Association to CVD Risk Factors Than Postprandial Glycemia or Glucose Variability (2009) (0)
Caveats regarding the use of HbA1c for prediction of mean blood glucose. Reply to Chalew S, Hempe JM [letter] (2008) (0)
EFFECT OF NEPHRECTOMY ON BLOOD-TRANSFUSION REQUIREMENTS (1969) (0)
"Myelophrenia": its contribution to the management of aplastic anemia. (1984) (0)
549 VISUALIZATION OF HUMAN GLOBIN GENES BY RESTRICTION ENDONUCLEASE MAPPING: A NEW APPROACH TO THE PRENATAL DIAGNOSIS OF GLOBIN GENE DELETION (1978) (0)
PERSPECTIVE Treatment of Cooley’s Anemia (2003) (0)
NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells (2013) (0)
Cynomolgus Monkey Invariant NKT (iNKT) Cells Recover Following Depletion by Treatment with the Anti-Invariant T Cell Receptor Antibody NKTT120 (2012) (0)
Values for Intra cellular Content of Sod ium and Potassium in Leukocytes (2005) (0)
801 ABSENCE OF COMMON ALL ANTIGEN ON NORMAL PLURIPOTENTIAL MYELOID, ERYTHROID AND GRANULOCYTE PROGENITORS (1981) (0)
The adenosine A2A receptor agonist regadenoson decreases activation of invariant NKT cells in human sickle cell subjects (2012) (0)
Authors’ response (2007) (0)
A Prospective Study of Inflammatory Biomarkers and Diabetic Retinopathy in Type 1 Diabetes Mellitus (2003) (0)
A decade of switch meetings: 1978-1988. (1989) (0)
Judah Folkman, MD (1933–2008) (2008) (0)
Announcement: THE ASSOCIATION OF MEDICAL SCHOOL PEDIATRIC DEPARTMENT CHAIRMEN, INC. (1990) (0)
Dr. Nathan's Reply to His Critics (1974) (0)
Letter: Nitroblue-tetrazolium tests. (1975) (0)
Pathophysiology of the Anaemia in Thalassaemia (2008) (0)
Selective Destruction of Reticulocytes (Retics) in Pyruvate Kinase (PK) Deficiency (1970) (0)
The query corner (1958) (0)
COLOR ATLAS AND TEXTBOOK OF HEMATOLOGY, edited by William R. Platt, M.D., F.C.A.P., F.A.C.P. Philadelphia: J. B. Lippincott, 1969, 445 pp., 135 illustrations, 73 color plates, $27.00 (1970) (0)
Editorial: The thalassemia syndromes. (1976) (0)
INTENSIVE THERAPY PRESERVES INSULIN SECRETION. AUTHOR'S REPLY (1998) (0)
Acquired aplastic anemias: pathophysiology and treatment. (1982) (0)
THE REGULATION OF HUMAN ERYTHROPOIESIS BY GROWTH FACTORS (1988) (0)
Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease (2011) (0)
Relationship of myocardial scar with cardiovascular disease risk factors in the diabetes control and complications trial (DCCT)/epidemiology of diabetes interventions and complications (EDIC) study (2010) (0)
Progress in thalassemia research (1979) (0)
Observations on the compensatory response to hypoxemia in a case of reversed differential cyanosis. (1972) (0)
142-OR: Health Care Coverage and Access and Associations with Glycemic Control in Young Adults with Youth-Onset Diabetes: The SEARCH for Diabetes in Youth and TODAY Studies (2021) (0)
Abstract: 989 OBESITY AND DIABETES PREVENTION (2009) (0)
Book ReviewHuman Hemoglobin Genetics (1986) (0)
Effects of Aspirin and Clopidogrel on Retinal Hemodynamics in Type 1 Diabetes (2007) (0)
Increased Susceptibility to Infection Due to Dysfunction of Granulocytes (1970) (0)
Expression and Function of the Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor (2002) (0)
Nutrition classics: the Journal of Clinical Investigation, volume 43, 1964. Iron deficiency anemia associated with an error of iron metabolism in two siblings. (1983) (0)
Regulation of the human interleukin-3 gene. (1989) (0)
CHELATION THERAPY IN OLDER PATIENTS WITH THALASSEMIA MAJOR (1984) (0)
HIGH DOSE METHOTREXATE (HDM) WITH CITROVORUM (CF) RESCUE IN THE MANAGEMENT OF BONE TUMORS (1974) (0)
Cost-effectiveness of Medical Nutrition Therapy in the Treatment of Hypercholesterolemia. (1998) (0)
Human Sickle Cell Disease Increases Numbers and Activation Of Peripheral Blood Myeloid Dendritic Cells, Monocytes, and Neutrophils (2013) (0)
Control of Blood Sugar in Insulin-Requiring Diabetes (1981) (0)
Prediction of severity of disease in homozygous β thalassemia (β thal) (1971) (0)
Letter: Phagocytosis studied with tetrazolium salts in 1953. (1974) (0)
Book ReviewHereditary Disorders of Erythrocyte Metabolism: Proceeding of the symposium held February 13–15, 1967, at the City of Hope Medical Center, Duarte, California. (1968) (0)
Biographical Memoirs: Stanley J. Korsmeyer (2007) (0)
Musings on genome medicine: the Obama effect redux (2009) (0)
CULTURED CELLS IN MARROW TRANSPLANTATION 1113 recipients of cultured marrow cells with major H-2 histocompatibility differences (2005) (0)
ERYTHROID CELL MATURATION IN MEGALOBLASTIC ANEMIA with the in vitro findings of Thomas and Lochte (0)
Successful bone marrow transplantation in sensitized recipients. [Effect of in vitro irradiation on cytotoxicity of bone marrow cells] (1979) (0)
Hemoglobin and its diseases : a subject collection from Cold Spring Harbor perspectives in medicine (2013) (0)
65 PSYCHOLOGICAL COSTS OF SURVIVING CHILDHOOD CANCER (1978) (0)
Visual analysis of cell-culture derived CHIKV strain INDO23574. (2013) (0)
Ads promoting unnecessary tests. (1979) (0)
Letter To The Editor (1970) (0)
New methods for monitoring insulin-dependent diabetes clinical application and results. (1986) (0)
Progenitor cells: megakaryocyte development and function. (1987) (0)
15 A Half Century of Clinical Research (2016) (0)
Rapid Publication Hydroxyurea Enhances Fetal Hemoglobin Production in Sickle Cell Anemia (2013) (0)
Intensive Therapy Preserves Insulin Secretion (1998) (0)
Call for a slower approach to health care reform. (2009) (0)
Iron Anemia Associated With An Error Of Iron Metabolism In Two Siblings (2009) (0)
Consensus Reports (2011) (0)
Correction: NF-κB Is Activated in CD4+ iNKT Cells by Sickle Cell Disease and Mediates Rapid Induction of Adenosine A2A Receptors (2015) (0)
William Bosworth Castle (October 21, 1897-August 9, 1990). (1991) (0)
Response to Davidson (1995) (0)
Book Review Science and the Quiet Art: The role of medical research in health care By David Weatherall. 337 pp. New York, W.W. Norton, 1994. $25. 0-393-03744-4 (1995) (0)
547 A METHOD FOR THE PRENATAL DIAGNOSIS OF CHRONIC GRANULOMATOUS DISEASE (CGD) (1978) (0)
Molecular Medicine Milestones (1996) (0)
Acute Hemodynamic Effects of Erythropheresis in 22 Patients with Severe Polycythemia Secondary to Cyanotic Congenital Heart Disease (2005) (0)
Reply (1992) (0)
Diet for IDDM Patients on CSII: A Reply (1984) (0)
Treatment of congenital bone marrow failure with cytokines (1992) (0)
UPDATE of the Journals (1982) (0)
A tribute to Emil Frei III (2013) (0)
A physician or group of physicians considers presentation and evolution of a real clinical case, reacting to clinical information and data (boldface type). This is followed by a discussion/commentary Hereditary xerocytosis revisited (2014) (0)
A Life in Hematology (2014) (0)
Frederick Stohlman, Jr., M.D. (1975) (0)
1051 FED-UP PHAGOCYTES: SPLENIC MACROPHAGE FUNCTION IN GAUCHER'S DISEASE (1981) (0)
Musings on genome medicine: the Obama effect (2009) (0)
Letter: Primary health care and medical research. (1974) (0)
Turning blood red: The fight for life in Cooley’s anemia (2009) (0)
COMMENTS ON TREATMENT OF POLYCYTHEMIA VERA LEUKEMIA AS A COMPLICATION OF POLYCYTHEMIA VERA. (1966) (0)
SPLENIC “POLISHING”: REMOVAL OF HIGH MOLECULAR WEIGHT RED CELL (RBC)MEMBRANE PROTEIN DETRITUS BY THE SPLEEN (1974) (0)
allogenic bone marrow transplantation in the preparation of patients with congenital bone marrow disorders for Busulfan and total body irradiation as antihematopoietic stem cell agents (2013) (0)
Early termination of the Diabetes Control and Complications Trial (2006) (0)
Stromal CellAssociated CellAssociated CellAssociated Erythropoiesis By (2005) (0)
HAEMOGLOBIN SYNTHESIS IN ERYTHROID CULTURE (1982) (0)
Sickle cell disease and stroke Running Head: Left: VERDUZCO and NATHAN Right: SICKLE CELL DISEASE AND STROKE (2009) (0)
Is 1,5 AnhydroGlucitol associated with malondialdehyde a marker for oxidative stress? (2009) (0)
Lack of Association Between the Trp 719 Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control (2017) (0)
817 SUBCUTANEOUS DEFEROXAMINE (ScDF) PLUS HYPERTRANSFUSION (HiTx) IN THALASSEMIA MAJOR (TM): A THREE YEAR FOLLOW-UP (1981) (0)
Diagnosing diabetes mellitus — best practices still unclear (2018) (0)
Novel treatment for Diamond-Blackfan anemia? (2002) (0)
Musings on genome medicine: abuse of genetic tests (2009) (0)
APLASTIC ANAEMIA TREATED WITH SYNGENEIC BONE MARROW TRANSPLANTATION (1984) (0)
Protein-6 and Coronary Artery Disease in 19 Case-Control Studies Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like (2012) (0)
View 2 ( Measuring Control ) Consensus Statement : Postprandial Blood Glucose (0)
Health care and the senator Edward M Kennedy: a biography Adam Clymer (2000) (0)
Patient-Specific Inference of Average Glucose from Glycated Hemoglobin (2016) (0)
Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort (2022) (0)
The dependence of highly enriched bone marrow progenitors on hematopoietic growth factors and their response to recombinant erythropoietin (2017) (0)
Expression of the f 3-thalassemia gene in the first trimester fetus ( prenatal diagnosis / hemoglobin synthesis / human development ) (0)
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Myocardial Infarction Genetics Consortium * (2009) (0)
Inhibition of iNKT cells by adenosine A2A receptor activation in patients with sickle cell disease (45.1) (2012) (0)
Nobel Prize for Clinical Investigation. (1990) (0)
Frank H. Gardner, MD (1919-2013) (2013) (0)
Musings on genome medicine: Crohn's disease (2009) (0)
Assessing postprandial hyperglycaemia and glucose variability. The ADAG study (2009) (0)
NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial (2015) (0)
ADDRESSING THE 21 ST CENTURY DIABETES EPIDEMIC * — Based on a presentation by (0)
Musings on genome medicine: cholesterol and coronary artery disease (2009) (0)
Hypochromic anemia and hemochromatosis. Response to combined testosterone, pyridoxine, and liver extract therapy. (1962) (0)
Studies of hybrid hematopoietic growth factor receptors. (1994) (0)
Sickle Cell Disease: Diagnosis, Management, Education and Research, Co-Chairmen and Editors–Harold Abramson, M.D., John F. Bertles, M.D., and Doris L. Wethers, M.D. St. Louis: The C. V. Mosby Company, 1973, 352 pp., $29.50 (1973) (0)
Erratum. Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254-2261. (2022) (0)
Dedication (2007) (0)
Author ' s response to reviews Title : Changes in Glycemic Control from 1996 to 2006 among Adults with Type 2 Diabetes : A Longitudinal Cohort Study (2010) (0)
articleChanges in glycemic control from 1996 to 2006 among adults with type 2 diabetes : a longitudinal cohort study (2015) (0)
THE JEREMIAH METZGER LECTURE. (2016) (0)
Musings on genome medicine: the slow but inexorable process of medical care reform in the United States (2009) (0)
CLINICAL VARIATIONS HOLD IMPORTANT CLUES TO THE UNDERSTANDING AND IMPLEMENTATION OF THE DCCT RESULTS. AUTHORS' REPLIES (1996) (0)
Musings on genome medicine: cancer genetics and the promise of effective treatment (2009) (0)
Treatment of Diabetes - To Pump or Not to Pump. (2021) (0)
15. The Blood (1977) (0)
Serum Lipid Levels and Diabetic Retinopathy in Type 1 Diabetes Mellitus (2003) (0)
lymphohematopoietic engraftment eradication of the PNH clone and documentation of complete Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria (2011) (0)
851 EXERCISE-INDUCED HEMOLYSIS IN SICKLE CELL DISEASE (1981) (0)
Mary Ellen Beck Wohl, M.D.: 1932?2009. (2011) (0)
Tests of Glycemia in Diabetes Mellitus (2020) (0)
Founding a new field (2012) (0)
Coronary Artery Calcification in Type 2 Diabetes and Insulin Resistance: the Framingham Offspring Study (2001) (0)
36 for Diabetes Mellitus (1990) (0)
The molecular genetics of thalassemia. (1976) (0)
"To Sleep: Perchance to Dream" (2013) (0)
Letter to the editorThe reply (1988) (0)
The medical ethics of bone marrow transplantation in childhood. (1975) (0)
The respiratory distress syndrome and glcocorticoid treatment: the case for enzyme induction. (1975) (0)
Production in Sickle Cell Anemia (1984) (0)
The rewards of patience in bone marrow transplantation (2009) (0)
GEORGE WIDMER THORNE, MD: 1906–2004. (2005) (0)
1119-P: Persistent and Heterogeneous Long-Term Effects of the Diabetes Prevention Program (DPP) Intensive Lifestyle (ILS) Intervention on Diabetes Incidence (2022) (0)
cells stimulated with hematopoietic growth factors colony- stimulating factor receptor subunits in murine hematopoietic Enhanced expression of interleukin-3 and granulocyte-macrophage (2013) (0)
Age lability of normal and variant methemoglobin reductase (1971) (0)
Obituary: Fred S. Rosen (1930–2005) (2005) (0)
Franz Ingelfinger retires: a thank-you note from a Journal contributor. (1977) (0)
Position Statements (2011) (0)
92330936 A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus (1993) (0)
Molecular Medicine Society: A Great Start, a Great Future (1996) (0)
Your health in the 21st century. The best ways to beat diabetes. (2005) (0)
Correcting the Record on Anemia of Aging--a Statistical Reanalysis. (2023) (0)
Response to Moses (1996) (0)
Training (2018) (0)

This paper list is powered by the following services:

Other Resources About David G. Nathan

en.wikipedia.org

What Schools Are Affiliated With David G. Nathan?

David G. Nathan is affiliated with the following schools:

David G. Nathan's Academic­Influence.com Rankings